Thirumalai Chemicals Limited

NSE:TIRUMALCHM.NS

293.48 (INR) • At close June 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

20252024202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 20,495.120,715.121,322.419,969.810,849.110,824.212,575.413,105.910,327.5789,441.72110,722.58612,762.38313,714.99510,515.8227,685.2886,256.7934,702.2195,879.795,332.573,584.65
Cost of Revenue 15,867.116,849.915,311.712,319.26,6928,007.58,522.68,138.56,957.0326,634.2038,505.34310,247.04910,564.8458,335.056,088.524,811.4534,074.7744,300.8794,514.7073,264.338
Gross Profit 4,6283,865.26,010.77,650.64,157.12,816.74,052.84,967.43,370.5462,807.5182,217.2432,515.3343,150.152,180.7721,596.7681,445.341627.4441,578.912817.863320.312
Gross Profit Ratio 0.2260.1870.2820.3830.3830.260.3220.3790.3260.2970.2070.1970.230.2070.2080.2310.1330.2690.1530.089
Reseach & Development Expenses 024.725.326.42932.533.630.527.10618.31212.40711.60717.3810000016.31411.281
General & Administrative Expenses 0171.9194.6112.39578.683.382.561.11759.724025.72953.1550000000
Selling & Marketing Expenses 01,033.8994.81,187.1566.3508.8518.5590.3461.76728.8740432.949622.80000000
SG&A 884.71,205.71,189.41,299.4661.3587.4601.8672.8522.88588.598365.828892.171,056.5530000000
Other Expenses 02,696.8301.511.210.617.212.210.23.9684.1084.2334.0294.1883.9443.0232.0151.9381.988-362.702-47.596
Operating Expenses 884.73,865.24,705.63,777.12,441.62,419.32,339.32,308.42,111.0272,000.4641,984.7511,918.6862,014.7171,662.1361,215.982874.3761,184.88987.638379.01758.877
Operating Income 3,743.3-621,312.73,876.51,719.3395.11,713.52,6591,259.52548.356-68.029148.721644.63520.282248.276380.258-698.74467.823438.846261.435
Operating Income Ratio 0.183-0.0030.0620.1940.1580.0370.1360.2030.1220.058-0.0060.0120.0470.0020.0320.061-0.1490.080.0820.073
Total Other Income Expenses Net -4,151.8-283.5-44-148.6-168.3-15.8-24.9-129-155-244.847-383.297-755.336-498.515-394.779-180.138000-54.248-63.17
Income Before Tax -408.5-345.51,294.13,753.71,571.3381.61,688.62,5301,092.073548.356-68.029148.721644.63520.282248.276380.258-698.74467.823384.598198.265
Income Before Tax Ratio -0.02-0.0170.0610.1880.1450.0350.1340.1930.1060.058-0.0060.0120.0470.0020.0320.061-0.1490.080.0720.055
Income Tax Expense 52.542.4395.8941.4394.4149.9552.9825.6386.625226.83669.21830.052181.83911.08178.092121.368-239.298201.454132.71652.739
Net Income -461-387.9898.32,812.31,176.9231.71,135.71,704.4705.448321.52-137.247118.668438.0919.182179.446258.615-460.009266.706251.882145.526
Net Income Ratio -0.022-0.0190.0420.1410.1080.0210.090.130.0680.034-0.0130.0090.0320.0010.0230.041-0.0980.0450.0470.041
EPS -4.5-3.798.7727.4711.492.2611.0916.656.93.14-1.341.164.280.0891.752.53-4.492.612.461.42
EPS Diluted -4.5-3.798.7727.4711.492.2611.0916.656.93.14-1.341.164.280.0891.752.53-4.492.612.461.42
EBITDA 488645.42,163.44,523.72,275.6990.42,173.82,963.81,610.3964.816535.739841.1411,179.573628.686534.579703.281-435.169717.527595.518399.09
EBITDA Ratio 0.0240.0310.1010.2270.210.0910.1730.2260.1560.1020.050.0660.0860.060.070.112-0.0930.1220.1120.111